WASHINGTON – U.S. Senator Roy Blunt (Mo.),
Chairman of the Appropriations Subcommittee on Labor, Health and Human
Services, Education, and Related Agencies (Labor/HHS), today commended
the National Institutes of
Health (NIH) announcement that it awarded Missouri $6.4 million in funding for
opioid-related research. The funding, which was included in the Blunt-backed
FY2018 and FY2019 Labor/HHS appropriations bills, was awarded to Washington
University and Saint Louis University.
“Prioritizing resources for
opioid-related research is key to gaining a better understanding of how we can
more effectively combat this epidemic,” said Blunt. “These resources will
support initiatives focused on improving treatment services, preventing
addiction in the first place, and developing new non-addictive treatments for
pain management. I’ll keep working to ensure the NIH and medical professionals
have the tools they need to continue playing an important role in ending this
public health crisis.”
Blunt prioritized a total of $3.8
billion for opioid programs in the
FY2019 Labor/HHS appropriations bill, and $500 million
specifically for NIH research. Under Blunt’s chairmanship, funding for
opioid-related Labor/HHS programs has increased by more than $3.5 billion over
four years.
Following are details from the
announcement:
|
Recipient
|
Amount
|
Research Focus Area
|
|
Washington University
|
$265,360
|
Enhanced outcomes for infants
and children exposed to opioids
|
|
Washington University
|
$2,096,911
|
Novel medication options for
opioid use disorder
|
|
Washington University
|
$1,218,127
|
Preclinical and translational
research in pain management
|
|
Washington University
|
$637,127
|
New strategies to prevent and
treat opioid addiction
|
|
Saint Louis University
|
$2,156,764
|
Preclinical and translational
research in pain management
|
Back to Home
